Clinical Trials Browser

Prostatic Neoplasms, Castration-Resistant × niraparib × 90 days × Clear all

NCT03748641 2026-03-16

MAGNITUDE

Phase 3 Active not recruiting

765 enrolled 16 charts 1 FDA

Prostatic Neoplasms, Castration-Resistant

NCT03431350 2025-12-23

QUEST

Phase 2 Active not recruiting

136 enrolled 29 charts

Prostatic Neoplasms, Castration-Resistant